Lycopene as a Therapeutic Agent against Aflatoxin B1-Related Toxicity: Mechanistic Insights and Future Directions
Antioxidants · 11.04.2024 · 13 (4) · 452
DOI: 10.3390/antiox13040452 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 11.04.2024. Verfasst von Meng Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Pinduoduo-China Agricultural University Research Fund, Pinduoduo–China Agricultural University Research Fund.
Abstract (Originalsprache)
Aflatoxin (AFT) contamination poses a significant global public health and safety concern, prompting widespread apprehension. Of the various AFTs, aflatoxin B1 (AFB1) stands out for its pronounced toxicity and its association with a spectrum of chronic ailments, including cardiovascular disease, neurodegenerative disorders, and cancer. Lycopene, a lipid-soluble natural carotenoid, has emerged as a potential mitigator of the deleterious effects induced by AFB1 exposure, spanning cardiac injury, hepatotoxicity, nephrotoxicity, intestinal damage, and reproductive impairment. This protective mechanism operates by reducing oxidative stress, inflammation, and lipid peroxidation, and activating the mitochondrial apoptotic pathway, facilitating the activation of mitochondrial biogenesis, the endogenous antioxidant system, and the nuclear factor erythroid 2-related factor 2 (Nrf2)/kelch-like ECH-associated protein 1 (KEAP1) and peroxisome proliferator-activated receptor-γ coactivator-1 (PGC-1) pathways, as well as regulating the activities of cytochrome P450 (CYP450) enzymes. This review provides an overview of the protective effects of lycopene against AFB1 exposure-induced toxicity and the underlying molecular mechanisms. Furthermore, it explores the safety profile and potential clinical applications of lycopene. The present review underscores lycopene’s potential as a promising detoxification agent against AFB1 exposure, with the intent to stimulate further research and practical utilization in this domain.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China.
- College of Life Sciences, Yantai University, Yantai 264000, China.
- Cardiovascular and Thoracic Surgery, Advanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- College of Veterinary Medicine, Northeast Agricultural University, 600 Changjiang Road, Xiangfang District, Harbin 150030, China.
ORCID-Profile: Gaurav Sharma, Shutao Yin, Zhihui Hao, Chongshan Dai
Förderung
- National Natural Science Foundation of China
- Pinduoduo-China Agricultural University Research Fund
- Pinduoduo–China Agricultural University Research Fund
Zitieren
APA
Li, M., Tang, S., Peng, X., Sharma, G., Yin, S., Hao, Z., Li, J., Shen, J., & Dai, C. (2024). Lycopene as a Therapeutic Agent against Aflatoxin B1-Related Toxicity: Mechanistic Insights and Future Directions. Antioxidants, 13(4), 452. https://doi.org/10.3390/antiox13040452
Vancouver
Li M, Tang S, Peng X, Sharma G, Yin S, Hao Z, et al. Lycopene as a Therapeutic Agent against Aflatoxin B1-Related Toxicity: Mechanistic Insights and Future Directions. Antioxidants. 2024;13(4):452. doi:10.3390/antiox13040452
BibTeX
@article{Li2024,
author = {Li, Meng and Tang, Shusheng and Peng, Xinyan and Sharma, Gaurav and Yin, Shutao and Hao, Zhihui and Li, Jichang and Shen, Jianzhong and Dai, Chongshan},
title = {Lycopene as a Therapeutic Agent against Aflatoxin B1-Related Toxicity: Mechanistic Insights and Future Directions},
journal = {Antioxidants},
year = {2024},
volume = {13},
number = {4},
pages = {452},
doi = {10.3390/antiox13040452}
}
EUVIMED